The extensive scope and intensive coverage of new developments in cancer therapeutics
at this annual educational activity provide cancer care providers with the opportunity to
learn about the new agents, new modalities, clinical trials and emerging developments
that will result in continuing progress towards the control and cure of cancer.
At the conclusion of the program participants should be able to:
Oncologists, Hematologists, Breast Cancer Oncologists, Gynecological Oncologists, Surgical Oncologists, Pediatric Oncologists, Radiotherapists, Immunologists, Oncology Nurses, Nurse Practitioners, Physician Assistants, Case Managers.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Icahn School of Medicine at Mount Sinai and The Chemotherapy Foundation. The Icahn School of Medicine at Mount Sinai is accredited by the ACCME to provide continuing medical education for physicians.
The Icahn School of Medicine at Mount Sinai designates this live activity for a maximum of 21 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Oncology Nurses, Nurse Practitioners, Physician Assistants, Case Managers
CME hours for the Wednesday through Friday sessions, may be submitted to credentialing organizations for acceptance of conversion to CE.
The NYS Council of Health-system Pharmacists is accredited by the New York State Council of Pharmacy Education as a provider of continuing pharmacy education. This activity has been approved for a total of 29.25 contact hours. Statements of continuing pharmacy education are available at healthsystemce.org upon the conclusion of the program. Participants must verify attendance at the meeting by entering the program CE code. Attendees have sixty days (60) to evaluate the program and obtain their statements of credit.
Verification of Attendance
Will be provided to all professionals.
FACULTY DISCLOSURE POLICY
It is the policy of the Icahn School of Medicine at Mount Sinai to ensure objectivity, balance, independence, transparency and scientific rigor in all CME sponsored educational activities. All faculty participating in the planning or implementation of a supported activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict-of-interest that may arise from the situation. Presenters must also make a meaningful disclosure to the audience in their discussions of unlabeled or unapproved drugs or devices.